Latest Enzymatica News & Updates
See the latest news and media coverage for Enzymatica. We track all announcements, press releases, and industry mentions in real time, all in one place.
Developer of enzyme-based viral infection defenses
enzymatica.com- Headquarters
- Lund, Sweden
- Founded year
- 2006
- Company type
- Public company
- Number of employees
- 25–50
Latest news about Enzymatica
Company announcements
-
Enzymatica’s CEO Sana Alajmovic discusses growth phase
She highlights scientific foundation, ColdZyme technology, international expansion, partnerships, and brand strengthening. The interview is with Redeye.
-
Enzymatica announces Q1 2026 quarterly report
Net sales are SEK 11.4 million. Partnership with STADA launches ColdZyme in Germany and Austria.
-
Enzymatica signs partnership with STADA for Germany and Austria
The agreement covers launch and distribution of ColdZyme oral spray. Commercial impact starts from 2026/2027 cold season via STADA's platform.
-
Enzymatica announces 2026 AGM notice
The meeting occurs on 7 May 2026 at 14:30 in Lund, Sweden. It includes proposals for board elections, auditor re-election, no dividend, and board authorization for new shares.
Media coverage
-
Enzymatica AB: Quarterly report Q1/2026 - Enzymatica strengthens international position through STADA agreement
The agreement marks an important breakthrough for Enzymatica and opens opportunities in one of Europe's largest self-care markets. Net sales for the quarter amounted to...
-
Enzymatica enters agreement with Stada in Germany | Affärsvärlden
The life-science company Enzymatica has signed a partnership agreement with Stada for the launch and distribution of Coldzyme in Germany and Austria.
-
Year-end report 2025: New CEO takes the helm - initiates the next phase of Enzymatica's international expansion
New CEO takes the helm - initiates the next phase of Enzymatica's international expansion...
-
Enzymatica increases turnover - reduces loss
Enzymatica, which markets the cold spray Coldzyme, reports an increased net turnover of 18.3 million kronor in the fourth quarter of 2025 (17.2).
Track Enzymatica and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Trending companies
Discover what's making headlines across other trending companies.
Sironax
Aperture Therapeutics
Attentive
Klaviyo
Twilio
Insider One
Zeta Global
Iterable
Braze
Optimove
Bluecore
BlueConic
Amperity
Wero
BLIK
EPI
Swish
Affirm
Brite Payments
TCS
Overview Energy
Adfin
Ineffable Intelligence
Mechanize
Hexatronic
Alimak Group
Lindab Group
NYAB
Noon Energy
Nordan AI
Mips
Vexlum
Asker Healthcare Group
FAKRO